New funding opportunity!
The Brain Tumor Funders' Collaborative has announced a new funding initiative aimed at accelerating development of non- or minimally- invasive methods for monitoring if, when, and how human brain tumors are responding to investigational therapies.
Both the National Brain Tumor Foundation and the Brain Tumor Society joined six other nonprofit philanthropic and advocacy organizations* to launch the Brain Tumor Funders' Collaborative (BTFC). Our goal is to promote collaborative, innovative, and novel research approaches for pre-clinical systems to accelerate more effective outcomes for patients with gliomas. This joint funding initiative provided three, $2 million, multi-year grants that began in 2006.
John Laterra, MD, PhD
Kennedy Krieger Institute- Johns Hopkins University
Baltimore, Maryland
Tumor stem cell-based drug discovery for adult and pediatric glioma
Paul Mischel, MD
David Geffen School of Medicine, University of California
Los Angeles, California
Molecularly guided clinical trials for glioma
Minesh Mehta, MD
American College of Radiology, Radiation Therapy Oncology Group
Identifying and overcoming resistance mechanisms in glioblastomas: a joint EORTC-RTOG effort
*Partners: American Brain Tumor Association, Brain Tumour Foundation of Canada, Children’s Brain Tumor Foundation, Goldhirsh Foundation, James S. McDonnell Foundation, and Sontag Foundation
